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During the G1/S transition, p21 proteolysis is
mediated by Skp2; however, p21 reaccumu-
lates in G2 and is degraded again in prometa-
phase. How p21 degradation is controlled in
mitosis remains unexplored. We found that
Cdc20 (an activator of the ubiquitin ligase
APC/C) binds p21 in cultured cells and identi-
fied a D box motif in p21 necessary for APC/
CCdc20-mediated ubiquitylation of p21. Overex-
pression of Cdc20 or Skp2 destabilized wild-
type p21; however, only Skp2, but not Cdc20,
was able to destabilize a p21(D box) mutant.
Silencing of Cdc20 induced an accumulation
of p21, increased the fraction of p21 bound to
Cdk1, and inhibited Cdk1 activity in p21+/+
prometaphase cells, but not in p21/ cells.
Thus, in prometaphase Cdc20 positively regu-
lates Cdk1 by mediating the degradation of
p21. We propose that the APC/CCdc20-medi-
ated degradation of p21 contributes to the full
activation of Cdk1 necessary for mitotic events
and prevents mitotic slippage during spindle
checkpoint activation.
INTRODUCTION
The cyclin-dependent kinase (CDK) inhibitor p21 is a criti-
cal negative regulator of the cell division cycle (Bloom and
Pagano, 2004; Pei and Xiong, 2005). Its N-terminal domain
binds to and inhibits cyclin-CDK complexes, while the
C-terminal domain binds to PCNA and inhibits the elonga-
tion of DNA synthesis. In agreement with these inhibitory
functions, levels of p21 increase in response to stimuli
that inhibit cell proliferation or induce differentiation and
senescence.
During an unperturbed cell cycle, p21 plays a role in G1
and G2 by contributing to temporal pauses that facilitate
the integration of critical checkpoint signals for regulated
entry into S phase and mitosis, respectively. While p21
contributes to the maintenance of the G1 state by inhibit-
ing the activity of Cdk2—and likely Cdk1 and Cdk3 as well
(Bloom and Pagano, 2004; Pei and Xiong, 2005)—in G2,462 Molecular Cell 27, 462–473, August 3, 2007 ª2007 Elseviethe major target of p21 is Cdk1 (Bates et al., 1998; Bunz
et al., 1998; Chan et al., 2000; Dulic et al., 1998; Medema
et al., 1998; Niculescu et al., 1998). Forced expression of
p21 inhibits DNA synthesis and entry into mitosis. In addi-
tion to these two well-known inhibitory effects, p21 overex-
pression induces polyploidy, particularly when the mitotic
spindle is disrupted with nocodazole (Bates et al., 1998;
Chang et al., 2000; Niculescu et al., 1998). However, the
reasons for this effect on ploidy are not well understood.
In nontransformed fibroblasts, p21 shows bimodal peri-
odicity, with an initial peak during G1 and a second peak in
G2, at both the mRNA and protein level (Dulic et al., 1998;
Li et al., 1994). Cells in G2 (displaying visible nucleoli and
no mitotic chromosome condensation) exhibit high levels
of nuclear p21 associated with Cdk1 complexes. In the
course of DNA condensation, p21 levels drop, and p21 re-
mains absent during mitosis (Dulic et al., 1998). How p21
degradation is controlled in early mitosis has not been in-
vestigated. In the study presented herein, we investigated
the regulation of p21 degradation in mitosis and found
that the ubiquitin ligase APC/CCdc20 (anaphase-promoting
complex/cyclosome and its activator Cdc20) controls this
process.
RESULTS
Cdc20 Physically Interacts with p21
Initially, we confirmed that p21 protein levels show a bi-
modal distribution during the cell cycle (Dulic et al., 1998).
Human T98G cells (Dorrello et al., 2006; Stein, 1979) were
synchronized in G0 by serum deprivation and released
from the arrest by the addition of serum. As expected,
cyclin E1 levels rose in late G1, and the increase in the
expression of Skp2, Cdc20, and cyclin A2 coincided with
the G1/S transition, inversely correlating with p27 levels
(Figure 1A). Levels of p21 were low in G0, increased in
G1, and decreased again at G1/S in parallel with p27 deg-
radation. However, whereas p27 expression remained low
for the remainder of the cell cycle, levels of p21 increased
28 hr after serum addition, when cells were exiting S phase
and approaching G2.
To pinpoint when p21 levels decrease again late in the
cell cycle, we synchronized IMR90 cells in S phase using
aphidicolin and then released them in fresh medium to
allow synchronized progression through G2 and mitosis.
Levels of p21 increased and reached a peak 12 hr afterr Inc.
Molecular Cell
Mitotic Degradation of p21 by APC/CCdc20Figure 1. p21 Is Degraded in Early Mitosis
(A) T98G cells were synchronized in G0 by 72 hr of serum starvation (indicated as time 0). Cells were then restimulated with serum and collected at
the indicated time points. Protein extracts were analyzed by immunoblotting with antibodies against the indicated proteins. Cell-cycle phases were
monitored by flow cytometry.
(B) IMR-90 fibroblasts were first synchronized in G0 by 72 hr of serum starvation and then at the G1/S boundary (indicated as time 0) by restimulating
them with serum for 28 hr, adding aphidicolin for the last 18 hr. Cells were subsequently washed and allowed to progress through the cell cycle for the
indicated times. Protein extracts were analyzed by immunoblotting with antibodies against the indicated proteins. Cell-cycle phases were monitored
by flow cytometry.aphidicolin release, then steadily decreased in coinci-
dence with the appearance of the Ser10 phosphorylation
of histone H3 (a marker of chromosome condensation)
and the degradation of cyclin A2 (Figure 1B). Similar be-
havior of p21 levels was observed in multiple cell types,
including T98G and U-2 OS (see Figure S1 in the Supple-
mental Data available with this article online).
The SCFSkp2 ubiquitin ligase is involved in the degrada-
tion of p21 (Bornstein et al., 2003; Wang et al., 2005; Yu
et al., 1998); therefore, we analyzed the levels of p21 in
cells lacking Skp2. Both Skp2/ and Skp2/;p27/
mouse embryonic fibroblasts (MEFs) displayed high levels
of p21 when synchronized in S phase (as previously ob-
served [Bornstein et al., 2003]), but not in G2 and prome-
taphase (Figure 2). Moreover, the physical interaction be-
tween Skp2 and p21 was significantly decreased in early
mitotic cells compared to S phase cells (data not shown).
Thus, to explore the possibility that p21 is targeted for
degradation by a different ubiquitin ligase, we screened
21 human F box proteins, two activators of the APC/C,
and the ubiquitin ligase Mdm2 for binding to p21. Con-
structs for the FLAG-tagged versions of these proteins
were transfected into HEK293T cells and, after the addi-
tion of the proteasome inhibitor MG132 6 hr prior to lysis,
immunoprecipitations for the ubiquitin ligases were per-
formed to evaluate their interaction with endogenous
p21. We observed that, in addition to Skp2, the only other
protein able to coimmunoprecipitate endogenous p21
was Cdc20 (Figure 3A). In contrast, related proteins suchMolecas Cdh1, bTrcp1, bTrcp2, Fbxw2, Fbxw4, Fbxw5,
Fbxw7a, Fbxw7g, or Fbxw8 (all of which, like Cdc20, con-
tain WD-40 repeats) did not bind p21 (Figure 3A). Similarly,
additional F box proteins (Fbxl2, Fbxl3, Fbxl7, Fbxl10,
Fbxl11, Fbxl15, Fbxl20, Fbxo4, Fbxo5, Fbxo7, Fbxo9,
Fbxo17, and Fbxo21) or Mdm2 also did not coimmuno-
precipitate p21 (Figure 3A and data not shown). Finally,
the interaction of p21 with Cdc20, as well as Cdc27 (an in-
tegral subunit of APC/C), was also observed for the en-
dogenous proteins (Figure 3B).
We then used seven Cdc20 mutants (Figure S2A) to map
the p21-binding domain in Cdc20. FLAG-tagged wild-type
Cdc20 and Cdc20 mutants were expressed in HEK293T
cells and then immunoprecipitated to evaluate their inter-
action with endogenous p21 and other proteins. The only
mutant that lost the ability to bind p21 was DC(471–499),
which lacks the last 19 amino acids (Figure S2B). This mu-
tant, as well as two different mutants with N-terminal de-
letions (DN133 and DN165), did not bind Cdc27 (Schwab
et al., 2001; Thornton et al., 2006; Figure S2B]. However, in
contrast to DC(471–499), DN133 and DN165 coimmuno-
precipitated p21 much more efficiently than wild-type
Cdc20 (Figure 3C and Figure S2B).
The APC/CCdc20-Mediated Ubiquitylation
and Degradation of p21 Requires
an Intact D Box Motif in p21
Results from the immunoprecipitation experiments de-
scribed above suggested that p21 may be a substrate ofular Cell 27, 462–473, August 3, 2007 ª2007 Elsevier Inc. 463
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Mitotic Degradation of p21 by APC/CCdc20APC/CCdc20 for the following reasons: (1) p21 interacted
with the C terminus of Cdc20, similarly to other substrates
of APC/CCdc20, such as cyclin A2 and Securin (Ohtoshi
et al., 2000 and data not shown). (2) Similarly to cyclin A2,
p21 bound more efficiently to DN165 than to wild-type
Cdc20 (Figure 3C). If p21 is a substrate of APC/CCdc20,
this difference could be explained by the differential bind-
ing of wild-type Cdc20 and DN165 to Cdc27. DN165 is
unable to bind Cdc27 and, therefore, could sequester
substrates without delivering them to the APC/C ligase
for ubiquitylation and consequent degradation. In con-
trast, wild-type Cdc20 binds p21, but it may also induce
p21 degradation. In favor of this hypothesis, the binding
between wild-type Cdc20 and p21 is not immediately de-
tectable without the addition of the proteasome inhibitor
MG132 prior to harvesting the cells (Figure 3C). (3) Wild-
type Cdc20 and DN165 also show a second differential
behavior. Whereas wild-type Cdc20 interacted better
with p21 and cyclin A2 in asynchronous cells than in prom-
etaphase cells, the opposite situation was observed for
DN165 (Figure 3C). This result suggests that in prometa-
phase cells, where APC/CCdc20 is more active, wild-type
Cdc20 is more competent in promoting the degradation
of p21 and cyclin A2, whereas DN165 is unable to do so,
allowing increasing amounts of p21 and cyclin A2 to bind.
Based on these considerations, we investigated the
involvement of APC/CCdc20 in controlling the degradation
of p21. We transfected HEK293T cells with a construct
expressing p21 and constructs expressing either Cdc20,
Cdh1, or Skp2 (Figure 4A). Enforced expression of Cdc20
Figure 2. Mitotic Degradation of p21 Is Not Dependent on
Skp2
MEFs from Skp2/;p27+/+, Skp2/;p27/, and Skp2+/+;p27+/+ mice
were synchronized at G1/S by a double thymidine block (S phase).
Cells were subsequently washed and allowed to progress through
the cell cycle for 12 hr in the presence of nocodazole. The prometa-
phase, round cells were collected by gentle shake-off, and finally,
the remaining attached cells (G2 phase) were also harvested. Protein
extracts were analyzed by immunoblotting with antibodies to the indi-
cated proteins.464 Molecular Cell 27, 462–473, August 3, 2007 ª2007 Elsevieor Skp2 resulted in a considerable decrease in the steady-
state amounts of p21 (Figure 4A, lanes 6 and 8), whereas
overexpression of Cdh1 had no effect (Figure 4A, lane 4).
Notably, both the Cdc20- and the Skp2-mediated de-
crease in p21 levels were due to the destabilization of the
CDK inhibitor, as shown by the ability of the proteasome
inhibitor MG132 to prevent this downregulation (Figure 4A,
lanes 7 and 9) and by the decrease in p21 half-life (Fig-
ure 4C, lanes 1–12). In contrast to wild-type Cdc20,
DN165 did not induce degradation of p21 (Figure 4D), sup-
porting the hypothesis that this mutant is inactive and un-
able to target p21 for degradation, regardless of its ability
to bind p21.
Substrates of APC/C are often characterized by the
presence of a ‘‘destruction box’’ or D box, which was first
identified in cyclin B as a stretch of nine amino acids
(RxxLxxIxN) that when mutated stabilized the protein
(Glotzer et al., 1991). However, most substrates contain
only the minimal RxxL motif in their D boxes. We identified
one conserved RxxL motif in p21 (positions 86–89 in hu-
man) that could potentially serve as a D box (Figure 4B),
but no other potential APC/C recognition motifs (KEN box,
A box, etc.) were identified. The RxxL domain of p21 is not
present in p27, does not overlap with either the CDK- or
the PCNA-binding domains, and is encompassed in a
low complexity region (amino acids 81–96), similar to the
D box motifs of A and B type cyclins. We mutated the
Arg and Leu residues in the putative D box motif to Ala
(Figure 4B) and determined the stability of the p21 D box
(p21[D box]) mutant in HEK293T cells coexpressing either
Cdc20 or Skp2. Notably, whereas the half-lives of both
wild-type p21 and p21(D box) mutant were shortened by
Skp2 (Figure 4C), p21(D box) mutant was refractory to
the effect of Cdc20 (Figure 4C, lanes 17–20).
To test whether p21 is ubiquitylated via the APC/CCdc20
ubiquitin ligase and further investigate the importance of
the D box motif, we reconstituted the ubiquitylation of
p21 in vitro. p21 ubiquitylation was promoted by the addi-
tion of APC/C and was further promoted by addition of
both APC/C and Cdc20 (Figure 4E). Methylated ubiquitin
added to the in vitro reaction inhibited the formation of
the highest molecular weight forms of p21 (Figure S3), for-
mally demonstrating that the high molecular weight forms
of p21 are indeed polyubiquitylated species. In contrast
to wild-type p21, a p21 deleted in the D box motif was
not efficiently ubiquitylated, even in the presence of both
APC/C and Cdc20 (Figure 4E and Figure S3).
Silencing of Cdc20 Stabilizes p21 in Early
Mitosis and Inhibits Cdk1 Activity
To confirm that Cdc20 is required for the degradation of
p21, we used the small interfering RNA (siRNA) technique
to reduce the expression of Cdc20. When compared
to cells transfected with control double-stranded RNA
(dsRNA) oligos, cells transfected with two different dsRNA
oligos targeting Cdc20 (including a previously validated
dsRNA oligo [Donzelli et al., 2002; Elbashir et al., 2001])
showed an upregulation of p21 levels (Figure 5A). Becauser Inc.
Molecular Cell
Mitotic Degradation of p21 by APC/CCdc20Figure 3. p21 Interacts with Cdc20
(A) HEK293T cells were transfected with an empty vector (EV) or constructs encoding the indicated FLAG-tagged F box proteins (FBPs), FLAG-Cdh1,
or FLAG-Cdc20, all in the presence of a plasmid encoding His-tagged Skp1. During the last 6 hr before harvesting, cells were treated with the
proteasome inhibitor MG132. Exogenous proteins were immunoprecipitated (IP) from whole-cell extracts (WCE) with an anti-FLAG resin, and immu-
nocomplexes were probed with antibodies to the indicated proteins.
(B) Endogenous Cdc20 and Cdc27 coimmunoprecipitate endogenous p21. Whole-cell extracts (WCE) from HeLa cells were immunoprecipitated (IP)
with normal IgG, anti-Cdc20, anti-Cdc27, or anti-Cdh1 antibodies. Immunocomplexes were probed with antibodies to the indicated proteins. The
second lane contained molecular weight markers (MWM) that appear to crossreact with the anti-cyclin A2 antibody.
(C) HeLa cells were infected with an empty vector (EV) or constructs encoding FLAG-tagged Cdc20 or FLAG-tagged Cdc20 DN165 mutant. Where
indicated, the proteasome inhibitor MG132 was added during the last 6 hr in culture. Exogenous proteins were immunoprecipitated (IP) from extracts
obtained from asynchronous (AS) or prometaphase (PM) cells using an anti-FLAG resin. Immunocomplexes were then probed with antibodies to the
indicated proteins.Cdc20 is mostly active in mitosis, the accumulation of p21
was presumably due to the mitotic fraction present in asyn-
chronous cells. In agreement with this hypothesis,
silencing of Cdc20 induced an increase in p21 levels only
in U-2 OS cells synchronized in prometaphase but not at
G1/S (Figure 5B). We also performed a complementary ex-
periment: U-2 OS cells arrested in prometaphase
with nocodazole were collected by mitotic shake-off and
then allowed to progress through mitosis and into the
next cell cycle. The levels of p21 were found to be low in
mitosis and to steadily increase during the G1 phase (con-
comitantly with an increase in p27 levels) (Figure 5C).
However, when Cdc20 was knocked down by siRNA, a de-
lay in the degradation of both p21 and cyclin A2 was ob-
served (Figure 5C). In addition, a delay in the exit from
mitosis was observed, as judged by flow cytometry and
the levels of phosphorylated Cdc27 and phosphorylated
histone H3.MolecThe fact that knockdown of Cdc20 is ineffective in
inducing an increase in p21 levels during G1 (Figure 5C),
G1/S (Figure 5B), and G2 (not shown) demonstrates that
Cdc20 promotes the degradation of p21 only in early mito-
sis. The accumulation of p21 in response to Cdc20 knock-
down both in unperturbed cells (Figure 5A and data not
shown) and in cells in which the spindle assembly check-
point is activated and sustained by nocodazole (Figures
5B and 5C), indicates that Cdc20 promotes p21 degrada-
tion irrespective of the spindle checkpoint.
Finally, we investigated whether downregulation of
Cdc20 in prometaphase affects the activity of Cdk1. After
downregulating Cdc20 in prometaphase HCT116 cells,
we observed an accumulation of p21 (Figure S4) and an in-
crease of p21 bound to Cdk1, cyclin A2, and cyclin B1 (Fig-
ure 6). Accordingly, the kinase activities associated with
these cyclin-CDK complexes were strongly reduced, as as-
sayed using histone H1 as a substrate. However, when theular Cell 27, 462–473, August 3, 2007 ª2007 Elsevier Inc. 465
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Mitotic Degradation of p21 by APC/CCdc20Figure 4. Cdc20-Dependent Ubiquitylation and Degradation of p21 Depend on the D Box of p21
(A) Whole-cell extracts were prepared from HEK293T cells transfected with p21 and either HA-tagged Cdc20, HA-tagged Cdh1, or HA-tagged Skp2.
Levels of p21 were detected by immunoblotting with an anti-p21 antibody, whereas Cdc20, Cdh1, and Skp2 were analyzed using an anti-HA anti-
body. Cul1 was used as a loading control. Where indicated, the proteasome inhibitor MG132 was added during the last 6 hr in culture. No significant
changes in the cell-cycle phases (as monitored by flow cytometry) of transfected HEK293T cells were observed compared to controls.
(B) Alignment of the amino acid regions corresponding to the putative Destruction box motif (D box) in human, mouse, and rat p21 with the D box
motifs of human cyclin B1, cyclin A2, and Nek2A. A schematic representation of the Arg-to-Ala and Leu-to-Ala substitutions in the putative D box
motif of human p21 is depicted at the bottom.
(C) HEK293T cells were transfected with wild-type p21 or the p21(D box) mutant in the presence of either an empty vector (EV), HA-tagged Cdc20, or
HA-tagged Skp2. Twenty-four hours after transfection, cells were treated with cycloheximide (CHX), and the half-life of p21 was analyzed by immu-
noblotting.
(D) HEK293T cells were transfected with wild-type p21 in the presence of either FLAG-tagged Cdc20 or FLAG-tagged Cdc20DN165 mutant. Twenty-
four hours after transfection, cells were treated with cycloheximide (CHX), and the half-life of p21 was analyzed by immunoblotting.
(E) In vitro ubiquitin ligation assay of 35S-labeled in vitro-transcribed/translated p21 or p21D(D box) mutant was conducted in the absence or presence
of immunopurified APC/C and constitutively active Cdc20(7A) mutant, as indicated. Samples were incubated at 30C for 90 min. The bracket on the
right side of the panels marks a ladder of bands corresponding to polyubiquitylated p21.same experiments were repeated in HCT116 p21/ cells
(Waldman et al., 1996), the kinase activities associated
with Cdk1 and cyclin B1 were unaffected. Cyclin A2 activity466 Molecular Cell 27, 462–473, August 3, 2007 ª2007 Elsevieincreased, because cyclin A2 is a substrate of APC/CCdc20.
These experiments show that Cdc20 is involved in the acti-
vation of Cdk1 by mediating the proteolysis of p21.r Inc.
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Mitotic Degradation of p21 by APC/CCdc20Figure 5. Cdc20 Targets p21 for Degradation in Prometaphase
(A) HeLa cells were transfected twice with siRNA molecules to a nonrelevant mRNA (lacZ) or to Cdc20 mRNA (the latter using two different siRNA
oligos: #1 and #2). Protein extracts were probed with antibodies to the indicated proteins.
(B) U-2 OS cells were transfected twice with siRNA oligos to a nonrelevant mRNA (lacZ) or to Cdc20 mRNA. Cells were then treated with aphidicolin for
24 hr to arrest cells at G1/S (first three lanes). In a parallel experiment, aphidicolin was washed away to allow cells to progress through the cell cycle for
an additional 18 hr in the presence of nocodazole (last three lanes). The prometaphase (PM), round cells were collected by gentle shake-off. Cell
extracts were subjected to immunoblotting with antibodies to the indicated proteins.
(C) U-2 OS cells were transfected twice with siRNA oligos corresponding to a nonrelevant mRNA (lacZ) or to Cdc20 mRNA. Twelve hours after the last
transfection, nocodazole (NZ) was added for an additional 16 hr. Round, prometaphase cells were then collected by gentle shake-off and replated
in fresh medium for the indicated times. Cells were harvested, and cell extracts were analyzed by immunoblotting with antibodies to the indicated
proteins. Cell-cycle phases were monitored by flow cytometry.DISCUSSION
Control of p21 Ubiquitylation by APC/CCdc20
and SCFSkp2 at Different Phases of the Cell Cycle
During cell-cycle progression, levels of p21 increase in G1
and then decrease at G1/S to free CDK and PCNA com-
plexes. Genetic and biochemical evidence indicates that
at G1/S the degradation of p21 (Bornstein et al., 2003;
Wang et al., 2005; Yu et al., 1998) and p27 (Guardavac-
caro and Pagano, 2006) is controlled by the SCFSkp2 ubiq-
uitin ligase. However, in contrast to p27, p21 levels rise
again in G2 and then decline once more in early M (Dulic
et al., 1998; Li et al., 1994; and Figures 1A and 1B). This
final decrease contributes to the full activation of Cdk1
(Bates et al., 1998; Bunz et al., 1998; Chan et al., 2000;
Dulic et al., 1998; Medema et al., 1998; Niculescu et al.,
1998), which is necessary for mitotic events.
During G2 and M, the SCFSkp2 ubiquitin ligase promotes
the degradation of p27 and likely additional substrates.
However, the mitotic phenotype present in Skp2/
MEFs and Skp2/ hepatocytes is not observed inMolecSkp2/;p27/ cells (Nakayama et al., 2004), strongly
advocating the idea that p27 is the major G2/M substrate
of Skp2 and that other substrates are degraded via differ-
ent or alternative routes. Accordingly, p21 accumulates in
Skp2/ and Skp2/;p27/ MEFs during S phase but
not in M (Figure 2). Herein, we show that p21 degradation
in mitosis is promoted by APC/CCdc20. This process re-
quires a conserved D box present in p21 (Figure 4). In con-
trast to APC/CCdc20, APC/CCdh1 does not induce the deg-
radation of p21. In fact, by promoting degradation of Skp2
and Cdc20 (Bashir et al., 2004; Reis et al., 2006; Wei et al.,
2004) APC/CCdh1 induces the stabilization of p21. Thus,
APC/C exerts dual control on p21 stability: during G1, it al-
lows p21 stabilization (via the Cdh1-mediated degrada-
tion of Skp2 and Cdc20), while in M, it induces the pro-
teolysis of p21 (via Cdc20). Moreover, APC/CCdc20
maintains dual control over Cdk1 activity: in early M,
Cdc20 promotes Cdk1 activation (by inducing the elimina-
tion of p21), whereas in late M, it induces Cdk1 inactivation
(by promoting the degradation of mitotic cyclins). Notably,
the positive effect of Cdc20 in the activation of Cdk1ular Cell 27, 462–473, August 3, 2007 ª2007 Elsevier Inc. 467
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Mitotic Degradation of p21 by APC/CCdc20Figure 6. Cdc20-Mediated Degradation of p21 Activates Cdk1 in Early Prometaphase
Hct116 p21+/+ and Hct116 p21–/– cells were transfected twice with siRNA oligos to a nonrelevant mRNA (lacZ) or to Cdc20 mRNA, as indicated. Cells
were then synchronized at G1/S using a double thymidine block and then released to allow cells to progress through the cell cycle for 18 hr (adding
nocodazole during the last 15 hr). Prometaphase cells were collected by gentle shake-off. Cell extracts were subjected to immunoprecipitation (IP)
with antibodies against Cdk1 (A), cyclin B1 (B), or cyclin A2 (C). Immunocomplexes were probed with antibodies to the indicated proteins (upper
panels) or used to perform kinase assays using histone H1 (HH1) as a substrate (bottom panels). The error bars represent ±SD from triplicate exper-
iments quantified by measuring radioactivity in the HH1 band excised from the dried gel. A representative experiment showing an autoradiograph of
32P-labeled HH1 is presented on the top of the bottom panels.during prometaphase is mediated by the induction of p21
proteolysis, as silencing of Cdc20 has no effect on Cdk1
activity in p21/ cells (Figure 6). While both APC/CCdc20
and APC/CCdh1 are known to be involved in either the
direct or indirect inactivation of CDKs (Peters, 2006), this
study demonstrates that APC/C also positively controls
the activity of a CDK, namely, Cdk1. Additionally,
whereas, with the exception of Nek2A, all substrates of
APC/CCdc20 identified so far in metazoans are also recog-
nized by APC/CCdh1, APC/CCdh1 has many specific sub-
strates (Acquaviva and Pines, 2006; Peters, 2006; Thorn-
ton and Toczyski, 2006). Thus, p21 represents a specific
substrate of metazoan APC/CCdc20.
In mitosis, the spindle assembly checkpoint inhibits the
separation of sister chromatids until the microtubules radi-
ating from the spindle poles are correctly attached to the
kinetochores. At a molecular level, the spindle checkpoint
ensures the inhibition of the bulk of APC/CCdc20 activity
to avoid the degradation of both Securin (to prevent the
separation of sister chromatids) and cyclin B (to prevent
a premature exit from mitosis). However, the reason for468 Molecular Cell 27, 462–473, August 3, 2007 ª2007 Elsevia subpopulation of APC/CCdc20 to remain active in the
presence of spindle checkpoint activity is not well under-
stood. Because Cdk1 inhibition overcomes the prometa-
phase arrest mediated by the spindle checkpoint (Brito
and Rieder, 2006; D’Angiolella et al., 2003), our results
suggest that APC/CCdc20-mediated degradation of p21
contributes to the maintenance of the high levels of
Cdk1 activity necessary to sustain the spindle checkpoint.
If p21 was not degraded at this time, Cdk1 would be in-
hibited with consequent, rapid adaptation to the spindle
checkpoint, resulting in mitotic slippage without cyto-
kinesis and consequent aneuploidy. Interestingly, forced
expression of p21 has been reported to cause polyploidy,
particularly after mitotic spindle disruption (Bates et al.,
1998; Chang et al., 2000; Niculescu et al., 1998).
There is extensive evidence in favor of Skp2-mediated
degradation of p21. First, in vitro ubiquitylation of p21 is
mediated by SCFSkp2 and its cofactor Cks1 and is pro-
moted by the phosphorylation of p21 on Ser130 by the
cyclin E-Cdk2 complex (Bornstein et al., 2003; Wang
et al., 2005; Zhu et al., 2005). A conserved glutamic acider Inc.
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Mitotic Degradation of p21 by APC/CCdc20at the –2 position of Ser130 is also involved in the binding
of p21 to SCFSkp2 (V.A. and M.P., unpublished data). The
corresponding residues in p27 (Glu185 and Thr187) play
a critical role in allowing p27 binding to the Skp2-Cks1
complex (Hao et al., 2005), suggesting that p21 and p27
are similarly recognized by SCFSkp2. Second, p21 is stabi-
lized in Skp2/ cells (Figure 2 and Bornstein et al., 2003),
when either Skp2 or Cul1 is downregulated (Figure 4;
Sarmento et al., 2005; Yu et al., 1998), or when a Cul1
dominant-negative mutant is overexpressed (J. Bloom,
R. Piva, and M.P., unpublished data). In addition, silencing
of the SCF modulator Cand1 (Y. Xiong, personal commu-
nication) or the inactivation of a temperature-sensitive
Nedd8-activating enzyme (Bloom et al., 2003), which is
required for optimal SCF activity, also induces a significant
accumulation of p21. Third, siRNA oligos targeting Cdh1
(a negative regulator of Skp2) or the forced expression
of Skp2 induce the degradation of p21 (Figure 4A; Bashir
et al., 2004; Wang et al., 2005). Despite this evidence, it
has been suggested that the accumulation of p21 in
Skp2/ MEFs is not due to a direct role of Skp2 in medi-
ating p21 degradation but rather is a result of an accumu-
lation of cyclin E (Chen et al., 2004), which would stabilize
p21 by a unknown mechanism. However, several data
conflict with this explanation: (1) p21 stabilization is also
observed under conditions in which cyclin E accumulation
is not observed, such as inSkp2/;p27/ MEFs (Figure 4
of Bornstein et al. [2003]), Figure 3 of Kossatz et al. [2004],
and Figure 2 of this paper) and after Skp2 silencing
(Figure 5B). (2) p21 is destabilized in response to the
forced expression of cyclin E (Wang et al., 2005). (3) A
p21 mutant deficient for interaction with cyclin-CDK
complexes displayed enhanced stability (Cayrol and
Ducommun, 1998). (4) Phosphorylation of p21 by cyclin
E-Cdk2 promotes its ubiquitylation and degradation
(Bornstein et al., 2003; Wang et al., 2005; Zhu et al.,
2005). (5) At G1/S, p21 is degraded in concomitance
with an increase in cyclin E levels (see, for example,
Figure 1A).
In conclusion, p21 is targeted by APC/C and SCF at dif-
ferent phases of the cell cycle, similar to other cell cycle
regulatory proteins such as Cdc25A (Guardavaccaro
and Pagano, 2006). Although our data indicate a role for
Skp2 in the proteolysis of p21 during S phase, we cannot
exclude that a minor fraction of p21 is also degraded via
Skp2 in mitosis, because silencing of Skp2 induces a slight
accumulation of p21 in prometaphase cells (Figure 5B).
The lack of p21 accumulation in mitotic Skp2/ MEFs
(Figure 2) could be in fact due to compensation by related
proteins during development, which cannot occur during
acute silencing of Skp2 in somatic cells.
Ubiquitin-Mediated and Ubiquitin-Independent
Degradation of p21
p21 is a short-lived protein and is degraded by the protea-
some. Ubiquitylated forms of both endogenously and ex-
ogenously expressed p21 have been detected in cultured
cells, and these ubiquitylated forms increase after protea-Molecsome inhibition (Bloom et al., 2003; Cayrol and Ducom-
mun, 1998; Coulombe et al., 2004; Fukuchi et al., 2002;
Maki and Howley, 1997; Maki et al., 1996; Rousseau
et al., 1999; Sheaff et al., 2000; Sugimoto et al., 2006),
suggesting that the proteasome degrades p21 marked
with ubiquitin chains. In spite of these reports, a ubiquitin-
independent, proteasome-dependent mechanism for p21
degradation has been proposed as the sole route for
proteolysis (Chen et al., 2004, 2007; Sheaff et al., 2000).
Initially, this theory was based on the observation that a ly-
sine-less p21 mutant (p21[K0]) is degraded with kinetics
similar to those of p21 wild-type. Because ubiquitin chains
are usually covalently bound to lysine residues of the sub-
strate, there was a potential that this mutant could not be
ubiquitylated. In contrast to this idea, two groups have
independently shown that the p21(K0) mutant is indeed
N-terminal ubiquitylated both in vitro and in vivo (Bloom
et al., 2003; Coulombe et al., 2004). In addition, two
temperature-sensitive cell lines carrying mutations in the
ubiquitin- and Nedd8-activating enzymes, respectively,
displayed stabilization of p21 at the restrictive tempera-
ture (Bloom et al., 2003; Coulombe et al., 2004; and F.
Bernassola and G. Melino, personal communication). Inhi-
bition of p21 ubiquitylation both in vitro (using methylated
ubiquitin) and in vivo (using a lysine-less ubiquitin mutant)
stabilized endogenous p21, as well as exogenous wild-
type p21 and a p21(K0) mutant (Bloom et al., 2003;
Coulombe et al., 2004). These experiments strongly indi-
cated that the degradation of p21 largely requires its
ubquitylation. The regulating function exerted by the
APC/CCdc20 and SCFSkp2 ubiquitin ligases on p21 stability
further confirms the role of the ubiquitin system in this
important biological process.
It is possible, however, that a fraction of cellular p21 is
degraded in a ubiquitin-independent manner. For exam-
ple, free recombinant p21, but not p21 bound to a cyclin-
CDK complex, is degraded in vitro by the proteasome
in the absence of ubiquitylation (Bloom et al., 2003; Liu
et al., 2003). This effect is due to the fact that p21 is na-
tively unfolded and, as such, can enter the proteasome
pore by free diffusion. Although we have been unable to
detect free p21 in extracts from human fibroblasts (Bloom
et al., 2003), it is conceivable that some free p21 exists, at
least transiently in certain cell types and under certain cel-
lular conditions, and that this fraction is degraded in
a ubiquitin-independent manner. Accordingly, a recent
study showed that only unbound p21 is targeted by the
proteasome in the absence of ubiquitylation, and this pro-
cess is limited to only certain cell lines (Li et al., 2007). To-
gether, these views would reconcile the ubiquitin-inde-
pendent and the ubiquitin-dependent theories of p21
degradation. In contrast, a hypothesis proposing the ubiq-
uitin-independent degradation of p21 as the only mecha-
nism cannot explain how the proteasome degrades, in
a temporally regulated fashion, p21 that is present in dif-
ferent protein complexes in the absence of ubiquitylation,
and why, if p21 is ubiquitylated in vivo, its degradation
should not require ubiquitylation.ular Cell 27, 462–473, August 3, 2007 ª2007 Elsevier Inc. 469
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for p21 Degradation
It has been reported that endogenous p21 is acetylated at
the N terminus (Figure 1 of Chen et al. [2004]). Based on
the assumption that mass spectrometry can quantitatively
attest that 100% of a protein is acetylated and that acety-
lation is irreversible, it has been inferred that endogenous
p21 cannot be ubiquitylated at the N terminus as N-termi-
nal acetylation would block N-terminal ubiquitylation.
However, in this experiment the p21 band for the mass
spectrometry analysis was excised from a gel, and there-
fore, slower-migrating, ubiquitylated species of p21 (which
potentially may not be acetylated) were not accounted for.
Moreover, N-terminal acetylation has been proposed as
corroboration for the ubiquitin-independent degradation
of p21, based on the belief that ubiquitylation of internal
lysines, although present, is not necessary for p21 degra-
dation. However, there is no evidence that ubiquitylation
of internal lysines is not required to target endogenous
p21 for degradation. Yet, when a p21(K0) mutant is ex-
pressed in mammalian cells, N-terminal ubiquitylation
appears as one possible way of p21 degradation. Accord-
ingly, a p21(K0) mutant tagged at the C terminus (and
therefore not interfering with N-terminal acetylation) is ro-
bustly ubiquitylated in vivo (Figure 5 in Bloom et al. [2003]).
Thus, ubiquitylation at the N terminus is sufficient for deg-
radation, though it may not be essential for endogenous
p21. Interestingly, Cdc20 and Skp2 are both able to in-
duce the degradation of the p21(K0) mutant (Figure S5),
suggesting that Cdc20 and Skp2 can use N-terminal ubiq-
uitylation of p21 to induce its degradation, at least under
these particular circumstances.
Conclusions
p21 contributes to the maintenance of the G2 state by in-
hibiting Cdk1 activity (Bates et al., 1998; Bunz et al., 1998;
Chan et al., 2000; Dulic et al., 1998; Medema et al., 1998;
Figure 7. Model of Cdk1 Autoactivation via Three Feedback
Loops, Including the Activation of the APC/CCdc20-Mediated
Degradation of p21 Occurring in Early Mitosis
Black signifies activated forms of the respective proteins, gray indi-
cates inactive forms or degraded proteins. Solid lines indicate activat-
ing (/) or inhibitory (–I) activities in prometaphase; dotted lines indicate
activating or inhibitory activities in different phase of the cell cycle. See
text for details.470 Molecular Cell 27, 462–473, August 3, 2007 ª2007 ElsevieNiculescu et al., 1998). It is well established that Cdk1 pro-
motes its own full activation through two amplification
loops, one involving the activation or stabilization of its
activators (the Cdc25 phosphatases) and a second pro-
moting the degradation of its inhibitor (the Wee1 kinase)
(Guardavaccaro and Pagano, 2006). Our results suggest
a positive feedback model where Cdk1, by phosphorylat-
ing certain subunits of APC/CCdc20, promotes the activity
of APC/CCdc20 (Peters, 2006), consequently triggering the
degradation of p21, resulting in a further activation of Cdk1
(Figure 7). We propose that the degradation of p21 via
APC/CCdc20 contributes to the full activation of Cdk1 in
early M and prevents mitotic slippage during activation
of the spindle assembly checkpoint.
EXPERIMENTAL PROCEDURES
Cell Culture, Synchronization, and Treatment with Drugs
T98G cells are revertants from T98 glioblastoma cells that acquired the
ability to arrest in G0/G1 in low serum (Dorrello et al., 2006; Lisztwan
et al., 1998; Stein, 1979). Normal human fetal lung fibroblasts
(IMR-90) were obtained from the American Type Culture Collection.
HEK293T, IMR90, U-2 OS, HeLa, and T98G cells and MEFs from
Skp2/;p27+/+, Skp2/;p27/, and wild-type littermate control
mice (Skp2+/+;p27+/+) were maintained in Dulbecco’s modified Eagle’s
medium containing 10% fetal calf serum (FCS). Skp2/;p27+/+,
Skp2/;p27/, and wild-type MEFs were a gift from K. Nakayama
(Kyushu University). HCT116 p21+/+ and HCT116 p21/ colon cancer
cells (Waldman et al., 1996) were a gift from B. Vogelstein (Johns
Hopkins University). T98G and IMR90 cells were serum starved in
the presence of 0.02% and 0.2% FCS, respectively, as previously
described (Dorrello et al., 2006; Lisztwan et al., 1998). Cells were
synchronized at G1/S using aphidicolin (2 mg/ml) or a double thymidine
block (2.5 mM), as described (Peschiaroli et al., 2006). Synchronization
in prometaphase with nocodazole and mitotic shake-off was per-
formed as described (Guardavaccaro et al., 2003). To test the in vivo
interaction between different proteins and endogenous p21, the
proteasome inhibitor MG132 (10 mM final concentration) was added
for 6 hr prior to harvesting the cells. To measure protein half-lives, cells
were incubated in the presence of 100 mg/ml cycloheximide
(CHX) (Sigma-Aldrich) diluted in 100% ethanol. Cell-cycle phases
were monitored by flow cytometry, as described (Carrano and Pagano,
2001).
Biochemical Methods
Extract preparation, immunoprecipitation, and immunoblotting were
previously described (Dorrello et al., 2006; Busino et al., 2007). Rabbit
polyclonal antibodies were from Santa Cruz Biotechnology (against
p21, Cdc20, and HA-tag). Mouse monoclonal antibodies were from
Sigma-Aldrich (anti-Cdc27 and FLAG), Lab Vision (anti-Cdh1), Invitro-
gen (anti-Cul1, anti-Skp1, and anti-Skp2), Covance (anti-HA), and BD
Transduction Laboratories (anti-p21 and anti-p27). The rabbit poly-
clonal antibodies against Cdk1, cyclin A2, cyclin B1, cyclin E1, and
phospho-histone H3 were previously described (Carrano et al., 1999;
Peschiaroli et al., 2006). Histone H1 kinase reactions were performed
as described (Carrano and Pagano, 2001).
Plasmids
Cdc20 and p21 point mutants were generated using the QuikChange
Site-Directed Mutagenesis Kit (Stratagene). Deletion mutants were
generated by a PCR-based approach. All constructs were sequenced
prior to use, and primer sequences are available upon request.r Inc.
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HEK293T cells were transfected using the calcium phosphate method
as described (Bashir et al., 2004). U-2 OS cells were transiently trans-
fected using ExGen 500 reagent (Fermentas), according to the manu-
facturer’s instructions. For experiments investigating the ability of
Cdc20 to induce the degradation of p21 (Figure 4), Cdc20 and p21
were cotransfected in a 3:1 ratio. For retrovirus production, packaging
GP-293 cells (Clontech) were transfected with FuGENE transfection
reagent (Roche) according to the manufacturer’s instructions. Forty-
eight hours after transfection, the virus-containing medium was col-
lected and supplemented with 8 mg/ml polybrene (Sigma). Cells were
then infected by replacing the cell culture medium with the viral super-
natant for 6 hr.
In Vitro Ubiquitylation Assay
Ubiquitylation assays were carried out using a procedure based on
a combination of previously described protocols (Fang et al., 1998;
Kramer et al., 1998). Briefly, prometaphase HeLa cells were washed
with PBS and lysed for 30 min on ice using Triton buffer (50 mM Tris
[pH 7.5], 250 mM NaCl, 0.1% Triton X-100, 1 mM EDTA, 1 mM DTT,
and phosphatase and protease inhibitors). An anti-Cdc27 antibody
(15 mg) was added to 10 mg of cell extract and incubated for 3 hr
at 4C. Protein G agarose was then added and incubated for 45 min
at 4C on a rotating wheel. The beads were washed four times in Triton
buffer and four times in QA buffer (10 mM Tris-HCl [pH 7.5], 100 mM
KCl, 1 mM MgCl2, 0.1 mM CaCl2, and 1 mM DTT). In vitro-tran-
scribed/translated, unlabeled, constitutively active Cdc20(7A) mutant
(Yudkovsky et al., 2000) was added and incubated 30 min at 37C.
The beads were subsequently washed three times with QA buffer.
The resulting beads were used for two reactions of in vitro ubiquityla-
tion. Ubiquitylation assays were performed in a volume of 10 ml
containing 40 mM Tris (pH 7.6), 5 mM MgCl2, 1 mM DTT, 2 mM ATP,
1.5 mg/ml E1 (Boston Biochem), 20 mg/ml UbcH10 (Boston Biochem),
2.5 mg/ml ubiquitin (Sigma), 1 mM ubiquitin aldehyde, 0.25 mg/ml
cyclin A2/Cdk2 complex, 20 mM staurosporine, and 1 ml of in vitro-
transcribed/translated [35S]p21 as a substrate. Methyl-ubiquitin
(0.2 mg/ml) was added where indicated. The reactions were incubated
at 30C for the indicated times and analyzed by SDS-PAGE.
Gene Silencing by Small Interfering RNA
siRNA duplexes were transfected into cells using oligofectamine (Invi-
trogen) according to manufacturer’s instructions and as described
(Dorrello et al., 2006; Peschiaroli et al., 2006). Forty-eight hours after
transfection, cells were collected after further treatments. The siRNA
oligonucleotide sequence for Cdh1 was 50-AAUGAGAAGUCUCCCAG
UCAGdTdT-30 (corresponding to nt 199–219 of human Cdh1 cDNA).
The siRNA oligonucleotide sequences for Cdc20 were 50-AACGGCA
GGACUCCGGGCCGAdTdT-30 (oligo #1, corresponding to nt 156–
170 of human Cdc20 cDNA) and 50-AAUGGCCAGUGGUGGUAAU
GAdTdT-30 (oligo #2, corresponding to nt 969–989 of human Cdc20
cDNA). The siRNA oligonucleotide sequence for Skp2 was 50- AAGGG
AGUGACAAAGACUUUGdTdT-30 (corresponding to nt 218–238 of hu-
man Skp2 cDNA). A 21 nt siRNA duplex corresponding to a nonrelevant
gene (lacZ) was used as control.
Supplemental Data
Supplemental Data include five figures and Supplemental References
and can be found with this article online at http://www.molecule.org/
cgi/content/full/27/3/462/DC1/.
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